Pen Needles Market: Current Analysis and Forecast (2021-2027)

SKU ID :UMI-19159819 | Published Date: 16-Sep-2021 | No. of pages: 182
1 MARKET INTRODUCTION 1.1. Market Definitions 1.2. Objective of the Study 1.3. Limitation 1.4. Stake Holders 1.5. Currency Used in Report 1.6. Scope of the Global Pen Needles Market Study 2 RESEARCH METHODOLOGY OR ASSUMPTION 2.1. Research Methodology for the Global Pen Needles Market 2.1.1. Main Objective of the Global Pen Needles Market 3 MARKET SYNOPSIS 4 EXECUTIVE SUMMARY 5 GLOBAL PEN NEEDLES MARKET REVENUE (USD MN), 2019-2027F 6 MARKET INSIGHTS BY TYPE 6.1. Standard Pen Needles 6.2. Safety Pen Needles 7 MARKET INSIGHTS BY LENGTH 7.1. 4mm 7.2. 5mm 7.3. 6mm 7.4. 8mm 7.5. 10mm 7.6. 12mm 8 MARKET INSIGHTS BY THERAPY 8.1. Glucagon-like Peptides 8.2. Insulin 8.3. Growth Hormones 9 MARKET INSIGHTS BY MODE OF PURCHASE 9.1. Retail 9.2. Non-Retail 10 MARKET INSIGHTS BY REGION 10.1. North America Pen Needles Market 10.1.1. United States 10.1.2. Canada 10.1.3. Rest of North America 10.2. Europe Pen Needles Market 10.2.1. Germany 10.2.2. United Kingdom 10.2.3. France 10.2.4. Spain 10.2.5. Rest of Europe 10.3. Asia Pacific Pen Needles Market 10.3.1. China 10.3.2. Japan 10.3.3. India 10.3.4. Australia 10.3.5. Rest of Asia Pacific 10.4. Rest of the World Pen Needles Market 11 DEMAND AND SUPPLY SIDE ANALYSIS 11.1. Demand Side Analysis 11.2. Supply Side Analysis 11.2.1. Top Product Launches 11.2.2. Top Business Partnerships 11.2.3. Top Business Expansions, Investments and Divestitures 11.2.4. Top Merger and Acquisitions 12 VALUE CHAIN ANALYSIS 13 GLOBAL PEN NEEDLES MARKET TRENDS & INSIGHTS 14 GLOBAL PEN NEEDLES MARKET DYNAMICS 14.1. Market Drivers 14.2. Market Challenges 14.3. Impact Analysis 15 GLOBAL PEN NEEDLES MARKET OPPORTUNITIES 16 COMPETITIVE SCENARIO 16.1. Porter's Five Forces Analysis 16.1.1. Bargaining power of Supplier 16.1.2. Bargaining power of Buyer 16.1.3. Industry Rivalry 16.1.4. Availability of Substitute 16.1.5. Threat of new Entrants 16.2. Competitive Landscape 16.2.1. Company Shares, By Revenue 17 COMPANY PROFILED 17.1. Allinson Medical, Inc. 17.2. Artsana S.p.a 17.3. B. Braun Melsungen AG 17.4. Becton Dickinson and Company 17.5. HTL Strefa S.A. 17.6. Novo Nordisk 17.7. Owen Mumford Ltd. 17.8. Terumo Corporation 17.9. Ultimed Inc. 17.10. Ypsomed Holding AG 18 DISCLAIMER
Allinson Medical, Inc., Artsana S.p.a, B. Braun Melsungen AG, Becton Dickinson and Company, HTL Strefa S.A., Novo Nordisk, Owen Mumford Ltd., Terumo Corporation, Ultimed Inc., and Ypsomed Holding AG
  • PRICE
  • $3999
    $7577

Our Clients